{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:56:39Z","timestamp":1764194199865},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.clindermatol.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T08:28:11Z","timestamp":1474014491000},"page":"55-63","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acral manifestations of systemic diseases: Drug-induced and infectious diseases"],"prefix":"10.1016","volume":"35","author":[{"given":"Stefano","family":"Caccavale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.09.008_bb0005","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1046\/j.1528-1157.2001.12901.x","article-title":"A prospective study of the incidence of the purple glove syndrome","volume":"42","author":"Burneo","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0010","first-page":"23","article-title":"Extravasation from intravenous phenytoin","volume":"11","author":"Comer","year":"1984","journal-title":"Am J Intrav Ther Clin Nutr"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0015","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM198411013111817","article-title":"Soft-tissue damage associated with intravenous phenytoin","volume":"311","author":"Kilarski","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01376517-199212000-00011","article-title":"Purple glove syndrome: A complication of intravenous phenytoin","volume":"24","author":"Hanna","year":"1992","journal-title":"J Neurosurg Nurs"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/phar.1396","article-title":"Management of extravasation injuries: A focused evaluation of noncytotoxic medications","volume":"34","author":"Reynolds","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0030","doi-asserted-by":"crossref","first-page":"E281","DOI":"10.1016\/j.jemermed.2012.07.057","article-title":"Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department","volume":"44","author":"Scumpia","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0035","doi-asserted-by":"crossref","first-page":"123.e5","DOI":"10.1016\/j.ajem.2014.05.039","article-title":"Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: Mechanism still a dilemma","volume":"33","author":"Jain","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1756285608094263","article-title":"Recent and future advances in the treatment of status epilepticus","volume":"1","author":"Rosenow","year":"2008","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0045","doi-asserted-by":"crossref","unstructured":"Garbovsky LA, Drumheller BC, Perrone J. Purple Glove Syndrome after phenytoin or fosphenytoin administration: Review of reported cases and recommendations for prevention. J Med Toxicol. (in press).","DOI":"10.1007\/s13181-015-0490-z"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0050","series-title":"Braun-Falco\u2019s Dermatology","first-page":"456","article-title":"Cutaneous adverse drug reactions (Chapter 33)","author":"Bork","year":"2009"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4103\/0019-5154.143525","article-title":"Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: Report of a case and literature review of kinase inhibitors and blocking antibodies","volume":"59","author":"Bansal","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2008.01.001","article-title":"Chemotherapeutic agents and the skin: An update","volume":"58","author":"Heidary","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0065","doi-asserted-by":"crossref","first-page":"203.e1","DOI":"10.1016\/j.jaad.2014.04.014","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: Part I. Conventional chemotherapeutic drugs","volume":"71","author":"Reyes-Habito","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0070","doi-asserted-by":"crossref","first-page":"217.e1","DOI":"10.1016\/j.jaad.2014.04.013","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: Part II. Targeted therapy","volume":"71","author":"Reyes-Habito","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0075","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0190-9622(90)70302-X","article-title":"Papular-purpuric \u201cgloves and socks\u201d syndrome","volume":"23","author":"Harms","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0190-9622(08)80483-5","article-title":"Papular-purpuric \u201cgloves and socks\u201d syndrome: Primary infection with parvovirus B19?","volume":"25","author":"Bagot","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0085","first-page":"E4","article-title":"Papular purpuric gloves and socks syndrome. Presentation of a clinical case","volume":"12","author":"Segura Saint-Gerons","year":"2007","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/S1413-86702006000100013","article-title":"Papular-purpuric \u201cgloves and socks\u201d syndrome caused by parvovirus B19 infection in Brazil: A case report","volume":"10","author":"Toyoshima","year":"2006","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1354-523X.2003.00986.x","article-title":"Oral manifestations of papular-purpuric \u2018gloves and socks\u2019 syndrome due to parvovirus B19 infection: The first case presented in Greece and review of the literature","volume":"10","author":"Sklavounou-Andrikopoulou","year":"2004","journal-title":"Oral Dis"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clindermatol.2014.12.011","article-title":"Update on hand-foot-and-mouth disease","volume":"33","author":"Ventarola","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1586\/14787210.2015.1058156","article-title":"Coxsackievirus A6: A new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide","volume":"13","author":"Bian","year":"2015","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3949\/ccjm.81a.13132","article-title":"Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome","volume":"81","author":"Repass","year":"2014","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaad.2005.09.033","article-title":"Gianotti-Crosti syndrome","volume":"54","author":"Brandt","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0120","first-page":"678","article-title":"Rilievi di una particolare casistica tossinfettiva caraterizzata de eruzione eritemato-infiltrativa desquamativa a foccolai lenticolari, a sede elettiva acroesposta","volume":"96","author":"Gianotti","year":"1955","journal-title":"G Ital Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0125","first-page":"132","article-title":"Papulo-eruptive dermatitis of the extremities in children","volume":"11","author":"Boyanov","year":"1960","journal-title":"Surv Med"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00105-002-0359-3","article-title":"Gianotti-Crosti syndrome following immunization","volume":"53","author":"Haug","year":"2002","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0135","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: A review for the practicing dermatologist","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.008_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D37V35W30D","article-title":"Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): A viral disease with an autoimmune component","volume":"9","author":"Aurelian","year":"2003","journal-title":"Dermatol Online J"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T16:29:57Z","timestamp":1657297797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16302279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0738081X16302279"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.09.008","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acral manifestations of systemic diseases: Drug-induced and infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}